Olanzapine (Zyprexa): A Novel Antipsychotic
Olanzapine (Zyprexa): A Novel Antipsychotic
Preço normal
€75,00 EUR
Preço normal
Preço de saldo
€75,00 EUR
Preço unitário
por
Imposto incluído.
Envio calculado na finalização da compra.
Não foi possível carregar a disponibilidade de recolha
Titulo: Olanzapine (Zyprexa): A Novel Antipsychotic
Autor: Pierre V. Tran, MD
ESTADO: NOVO
ISBN/EAN: 9780781724180
Editor: Lippincott Williams & Wilkins
Ano: 2000
Idioma: Inglês
Encadernação: N.A.
Páginas: 500
Coleção: N.A.
Nº. da Coleção: N.A.
Código de Controlo: 56G
Descrição: This volume presents detailed information on the unique pharmacological and clinical properties of a recently introduced antipsychotic drug, olanzapine. Chapters examine the molecular pharmacology and neurochemical actions of olanzapine, describe its behavioral and electrophysiological effects in animal models, and relate these preclinical findings to the drug's clinical profile. The book presents extensive clinical studies of olanzapine in the treatment of schizophrenia and other psychiatric conditions, such as cognitive symptoms, mood symptoms, and hostility and aggression. These studies suggest that olanzapine has a broader spectrum of efficacy than conventional antipsychotics and a lower incidence of extrapyramidal symptoms and other adverse effects
Ver detalhes completos
Autor: Pierre V. Tran, MD
ESTADO: NOVO
ISBN/EAN: 9780781724180
Editor: Lippincott Williams & Wilkins
Ano: 2000
Idioma: Inglês
Encadernação: N.A.
Páginas: 500
Coleção: N.A.
Nº. da Coleção: N.A.
Código de Controlo: 56G
Descrição: This volume presents detailed information on the unique pharmacological and clinical properties of a recently introduced antipsychotic drug, olanzapine. Chapters examine the molecular pharmacology and neurochemical actions of olanzapine, describe its behavioral and electrophysiological effects in animal models, and relate these preclinical findings to the drug's clinical profile. The book presents extensive clinical studies of olanzapine in the treatment of schizophrenia and other psychiatric conditions, such as cognitive symptoms, mood symptoms, and hostility and aggression. These studies suggest that olanzapine has a broader spectrum of efficacy than conventional antipsychotics and a lower incidence of extrapyramidal symptoms and other adverse effects
